DGAP-Adhoc: Balda AG: Management Board and Supervisory Board support the Offer of the Italian Stevanato Group in the amount of EUR 80 million regarding the purchase of the entire operating business – Extraordinary General Meeting probably at the end of January 2016

15.12.2015

Balda AG / Key word(s): Disposal

15.12.2015 15:47

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted

by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

—————————————————————————

Bad Oeynhausen, 15 December 2015 – As announced in an ad hoc announcement

yesterday, Balda AG received a binding offer by the Italian Stevanato Group

(“Stevanato”) regarding the sale of its entire operating business at a

purchase price of EUR 80 million on 14 December 2015.

The Annual General Meeting of Balda AG had already approved a binding offer

by the Heitkamp & Thumann Group, Düsseldorf (“H&T”), concerning the sale of

its entire operating business at a purchase price of EUR 74 million on 30

November / 1 December 2015. Balda AG so far has not accepted this offer.

The offer by Stevanato also comprises the sale of all operating units of

the Balda Group, namely Balda Medical GmbH & Co. KG, Balda C. Brewer, Inc.

and Balda Precision, Inc., both located in California, USA, as well as

Balda Medical Systems SRL, Romania, and further assets. Moreover, Stevanato

also offers to keep all employees of the operating units and take over

staff of Balda AG. Contrary to H&T, Stevanato intends to also purchase the

“Balda” brand and any associated (intangible) assets. The offer by

Stevanato is also subject to prior approval by the General Meeting of Balda

AG.

Meanwhile, the Management Board and the Supervisory Board have reviewed the

offer by Stevanato in detail and, taking all facts into account, regard the

offer by Stevanato preferable to the offer by H&T. In the next days, the

Management Board will convene an extraordinary General Meeting which will

presumably take place on 29 January 2016 in Hannover. At this extraordinary

General Meeting, the offer by Stevanato will be submitted to the General

Meeting for approval.

Contact / Contact Person:

Michael Pfister

Deekeling Arndt Advisors

tel: +49 (0) 5734 922 2555

moble: +49 (0) 160 90560506

email: michael.pfister@deekeling-arndt.de

About Balda

Balda (ISIN: DE0005215107) is a provider of high-end plastics solutions

that rely on quality in sophisticated fields of application in the

healthcare, lifestyle, automotive and consumer electronics industry. Balda

operates in Europe and Northern America and has state of the art production

sites at the Oeynhausen headquarters in Germany and in the US. The

company’s success with its about 800 staff worldwide is based on the use of

modern, cost-efficient technologies and the close cooperation with our

customers in a spirit of trust.

www.balda-group.com

15.12.2015 The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

—————————————————————————

Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen

Germany

Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604

E-mail: ir@balda-group.com

Internet: www.balda-group.com

ISIN: DE0005215107

WKN: 521510

Listed: Regulated Market in Frankfurt (Prime Standard); Regulated

Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,

Munich, Stuttgart

End of Announcement DGAP News-Service

—————————————————————————